OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Heart and Lung Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation	587
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial	425
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients	192
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant	176
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing	90
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass	89
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System	86
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation	82
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy	79
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients	76
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil	65
Early Onset Malignancy in the First-Year After Heart Transplantation	62
Older Donor Hearts for Heart Transplantation	59
WITHDRAWN	58
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension	58
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	56
Comparative Analysis of Fontan Transplant Outcomes	56
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes	54
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD	54
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience	53
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation	51
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients	50
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade	48
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients	48
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome	47

Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study	47
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status	47
Utility of Breath Volatomic Analysis in Lung Transplant Recipients	45
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models	44
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD	44
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis	43
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation	42
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience	41
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	41
INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION:EVOLUTION OF PROGNOSIS IN 10 YEARS OF NEW EMERGING THERAPIES	40
MINIMALLY INVASIVE PULMONARY ENDARTERECTOMY THROUGH INVERTED-T UPPER HEMISTERNOTOMY	40
Contemporary outcomes of mechanical circulatory support using paracorporeal continuous flow pump in children: A report from the ACTION learning network	38
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation	37
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial	36
Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing	36
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation	35
Ex-vivo lung perfusion: National trends and post-transplant outcomes	35
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis	33
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients	33
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support	32
Organ Care System (OCS) Perfusion Time During Donation After Circulatory Death (DCD) Heart Transplantation: Not Too Little, Not Too Much: There Safety Lie	32
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation	32
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series	32
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis	31
Cardiac Tamponade Associated to an Early EBV-Induced Lymphoma After Heart Transplantation: A Case Report	31
Pediatric Heart Transplantation in Donation After Circulatory Death Using Normothermic Regional Perfusion - Early Experience with Small Donors	31
Recurrence of pulmonary arterial hypertension 32 months after bilateral lung transplant	31
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep	30
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study	30
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation	29
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection	29
First North American Experience with The Berlin Heart Active Driver	29
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure	29
MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4/PD-1 pathway through the metabolic-epigenetic nexus	29
Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection	29
Extending the bridge, bridging the gap	28
Global Outcomes with Extended Criteria Donors When Preserved at 4-8°C: An Updated Analysis of the International GUARDIAN Heart Registry	28
Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Acute Decompensated Heart Failure	28
Outcomes in Children Supported with Paracorporeal Continuous Compared to Paracorporeal Pulsatile Ventricular Assist Devices	28
Mollicute Infections in Lung Transplant Patients: A Retrospective Review of Recipient Infections Post Initiation of a Screening Protocol	28
Conversion from Immediate Release Tacrolimus to LCP-Tacrolimus in Heart Transplant Recipients	28
Letermovir Use for Cytomegalovirus Prophylaxis in Lung Transplant Recipients	27
Outcomes After Heart Transplantation from Donors After Circulatory Death versus Brain Death: A Systematic Review and Meta-Analysis	27
The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients	27
Immunologic Outcomes Following Mycophenolate Dose Reduction in Lung Transplant Recipients	27
SRC Homology and Collagen (Shc) Inhibition: A Novel Therapeutic Strategy for Transplant-Related Pulmonary Fibrosis	26
Acute Myocarditis: Trying to Dissect Potential Prognostic Factors	26
Sternal Closure After Clamshell Thoracotomy for Bilateral Lung Transplantation: Comparison Between Different Techniques	26
Early Outcomes from the Use of Thoracic Epidural Analgesia versus INC Cryoablation during Lung Transplantation - A Single Center Experience	26
Single Nuclei Transcriptomic Analysis of Heart Allograft Ischemia-Reperfusion in a Rat Model	25

Post Transplant Malignancy Risk Factors in Thoracic Solid Organ Transplant Recipients	25
Pharmacist Managed Timing of Peri-Operative Plasmapheresis and Anti-Thymocyte Globulin in Heart Transplantation	25
A Single Centre Review of INR Monitoring in Patients Implanted with HeartMate 3 Ventricular Assist Device	25
Use of Heart in Donor Death Caused by Lightning	25
Impact of Donor Transfusions on Lung Transplant Outcomes: A National Cohort Analysis	25
Influence of Risk Factors on PTLD-Free Probability in Lung Transplant Patients: SRTR Database Analysis	25
Activation of cGAS-Dependent Necroptosis during Cold Static Preservation of Lungs Relies on Calcium	25
An Uncommon Driver of Waitlist Urgency: Recurrent Secondary Spontaneous Pneumothoraces of the Lung Allograft in a Single Lung Transplant (SLT) Recipient with CLAD	25
End Stage Heart Failure in Systemic Sclerosis- From Mechanical Circulatory Support to Heart Transplant	24
Midterm Outcomes in Orthotopic Heart Transplant Recipients with a History of Methamphetamine Use	24
A Bold Look: Evaluation of Skeletal Muscle Microvascular Function in Pediatric Heart Transplant Recipients Using Post-Contractile Blood Oxygen Level Dependent MRI	24
Evaluating age-based eligibility thresholds for heart re-transplantation – an analysis of the united network for organ sharing database	23
Donor Factors Contributing to the Increase in Adult Heart Transplant Volume in the United States	23
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation	23
Effect of Heparin Coated ECMO Circuit on AntiPF4 Antibodies	23
A rare case of late onset tacrolimus-induced leukoencephalopathy and coma after pediatric orthotopic heart transplantation	22
Information for Readers	22
Center volume effect on acute cellular rejection and outcomes in pediatric lung transplant recipients	22
(911) Older Donors in Lung Transplantation: The Portuguese Experience	22
Table of Contents	22
(904) Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes	22
Information for Readers	22
Alveolar macrophage subsets: Accessories to lung alloimmune rejection	22
Hemodynamic Modeling for Mitral Regurgitation	22
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients	22
Pulmonary Hypertension and Diastolic Heart Failure in an Adolescent African-American Cantú Syndrome Patient	21
(1033) Effect of Practice Variation Amongst Organ Procurement Organizations on Pediatric Donor Heart Utilization	21
Use of a Medication Questionnaire to Identify Lung Transplant Recipients Benefiting from Pharmacist Prioritization in Clinic	21
When a Single Choice Impacts a Single Ventricle: Paracorporeal Pediatric VAD Support at 544 Days	21
Oral Aversion and Its Risks in Pediatric Heart Transplant Recipients	21
(854) Effect of Dobutamine on Rv Contractility and Rv-Pa Coupling in the Normal Rv	21
Bedside Ultrasound of Internal Jugular Vein for Right Ventricular Function Assessment	21
Argon Inhalation Reduces Pulmonary Ischemia-Reperfusion Injury in MHC-inbred CLAWN Miniature Swine	21
Using Donor Lungs ≥70 Years of Age for Transplantation - Do Long-Term Outcomes Justify the Use?	21
Extending the Transplant Practitioner Role within the National Organ Retrieval Team to Include Organ Care Practitioner	21
Hemodynamic Implications of Sildenafil in Candidates for Heart Transplantation with Group 2 Pulmonary Hypertension: A Single Latin-American Center Registry	21
(742) Prognostic Value of Donor Specific Human Leukocyte Antibodies in Pre-Sensitized Heart Transplant Patients	20
(120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience	20
Hypogammaglobinemia in Patients Palliated with the Fontan Circulation: Implications for Cardiac Transplantation	20
(811) Incidence of Right Ventricular Dysfunction in Lvad Patients Bridged with High Dose Inotropes	20
(1215) Think Inside The Box: Constrictive Pericarditis after Pediatric Lung Transplant	20
(849) The Utility of Mechanical Circulatory Support in the Management of Massive Pulmonary Embolism with Right Ventricular Failure	20
(908) Does Donor-Recipient Sex Mismatch Have an Influence on Long Term Outcomes after Lung Transplantation? An Experience of a High Volume Center	20
(782) Use of Extracorporeal Membrane Oxygenation in Ranolazine Overdose	19
(151) Plasma Proteomic Signature of Human Heart Transplant Recipients After Restoration of Blood Circulation and Its Relationship to Graft Outcome	19
(1188) Assessment of Dd-cfDNA Between Stable Single and Double Lung Recipients	19
(797) Implantation from Short Term MCS to Durable VAD: Single Center Experience	19
(384) Urine Exosomes for Kidney Health Assessment in Mechanical Circulatory Support	19
(1206) Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients	19
(1226) Serum Proteomics for Fibrotic Markers in Early Detection of Bronchiolitis Obliterans Syndrome after Lung Transplantation	19
ISHLT 2023 Author Index	19
What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis	18
Imaging Mass Cytometry for Detailed Cellular and Spatial Characterization of Chronic Lung Allograft Dysfunction (CLAD)	18
Normothermic Ex Vivo Lung Perfusion (Novel) as an Assessment of Extended Criteria Donor Lungs: A Prospective Multi-Center Clinical Trial	18
Predictors of One-Year Outcome in Patients Undergoing Cardiac Re-Transplantation: Machine Learning Analysis	18
The Normalised Acute Rejection Score in the First Year Post Transplant and Its Association with CLAD	18
Kidney Transplantation in Single Ventricle Palliated Patients: A Pediatric Cardiac Care Consortium Study	18
(888) Initiating an ECMO Program at a Safety Net Hospital During a Global Pandemic	18
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection	18
Early Mammalian Target of Rapamycin Inhibitor Utilization After Heart Transplantation: Analysis of the UNOS Database	18
Lactic Acid and Metabolic Analysis of Human Donor Hearts Preserved with Organ Care System	18
Immune Characterization of a Xenogeneic Cross Circulation System for Ex Vivo Human Lung Support	18
Challenges in Heart Transplantation During COVID-19 Pandemic in Brazil	17
Comparison of LVAD Admissions Before and During the Era of COVID-19	17
Decoupling Between Pulmonary Artery Diastolic and Wedge Pressure Following TAVR	17
(715) Diaphragm Dysfunction from Covid-19 Phrenic Neuropathy: Utilization of Diaphragm Pacing for Recovery	17
(472) Giant Cell Myocarditis with LVAD Presenting with Acute Severe AI Managed with Valve-In-Valve TAVI	17
Polymicrobial and Multiple Blood Stream Infection Episodes as Risk Factors for On-Pump Mortality in Mechanical Circulatory Support Patients	17
Predictors of Failure to Rescue After Left Ventricular Assist Device Implantation	17
Safety of Single Lung Transplantation Post Donation Service Area-Specific Organ Distribution	17
Sequential Double-Lung Transplantation in Kartagener Syndrome: A Case Report	17
The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients	17
Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Use in Patients with Left-Ventricular Assist Device: Validation of the VT-LVAD Prediction Score	17
Heart Transplantation Utilizing Organs Following Donation After Circulatory Death (DCD)	17
(1153) Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant	17
(324) Stanford Pediatric Psychosocial Optimization Tool for Transplant	16
Optimizing the handling of missing data in the UNOS database	16
Lung Transplantation for Primary Ciliary Dyskinesia - A Single Center Review	16
Impact of Logistic Challenges on Cardiac Transplantation	16
New Rules, Improved Results: Successful Outcomes Bridging Patients Listed Status 1 for Heart Transplantation	16

Cardiac output assessment methods in left ventricular assist device patients: A problem of heteroscedasticity	16
Backwash Maneuver in LVAD Inflow Thrombosis: A Single-Center Experience (2015-2024)	16
Cold Blood Cardioplegia Use for Cardiac Arrest After Heart Transportation with Organ Care System May Improve Outcomes	16
Survival After Combined Lung and Liver Transplantation: A 22-year Single-Centre Retrospective Study	16
Enhancing Post-Lung Transplant Care with AlloHome: Early Impact Evaluation	16
(1270) Thermal Preconditioning During EVLP Reduces T Lymphocytes and Increases Monocytes and Neutrophils Contents in the Perfusion Solution	16
Extra-cardiac management of cardiogenic shock in the intensive care unit	16
Improved Oxygenation and Atelectasis in Brain-Dead (BD) Donors with a Novel Percutaneous Transvenous Phrenic Nerve Stimulator	16
Social Determinants of Health, Race and Their Relationship to Time in Therapeutic INR Range Following LVAD Implantation	16
Duration of Donor Cardiac Downtime in Donors After Circulatory Death Transplant	16
Comparing the Outcomes of Combined Heart-Liver Transplant Recipients from DCD and Non-DCD Donors: An Analysis Using the UNOS Database	16
“Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World”	15
Early Detection of Baseline Lung Allograft Dysfunction: The Concept of Pre-BLAD	15
Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study	15
Towards a nuanced understanding of donor risk	15
Absolute quantification of donor-derived cell-free DNA following pediatric and adult heart transplantation	15
Combination Approach of Perioperative Plasmapheresis and Eculizumab for Highly Sensitized Lung Transplant Patients	15
Durable Ventricular Assist Device Support with Systemic Right Ventricle Cannulation	15
Current Global Trends and Challenges Utilizing Pediatric Ventricular Assist Devices: An Action Collaborative Survey	15
Do Temporary Mechanical Circulatory Support Devices Activate Sensitization Pathways in Patients Awaiting Heart Transplantation?	15
Impact of Coronary Hypoperfusion During Agonal Phase on Outcomes Following Donation After Circulatory Death Heart Transplantation	15
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion	15
Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes	15
Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial	15
Kratom Toxicity: A Mimicker of Fulminant Myocarditis	15
Microcirculation as a Predictor of Clinical Outcomes in Left Ventricular Assist Device Therapy	15
WITHDRAWN	15
Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation	15
DCD heart transplantation with NRP: Excellent results and a continued uphill battle	15
Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study	15
Letter to the Editor: Can the grading of mild cardiac allograft vasculopathy be further refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1	15
Table of Contents	15
Does Donor-Recipient Age Mismatch Affect Long-Term Immunological Outcomes? A 10-Year Single Center Study	15
Shock Teams Grow Volume and Improve Outcomes in Cardiogenic Shock	15
Esophagogastric Junction (EGJ) Outflow Obstruction is Associated with Chronic Lung Allograft Dysfunction (CLAD)	14
Plasmablastic Lymphoma in a Lung Transplant Recipient	14
Differences in Prevention, Diagnosis, Surveillance and Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Patients: Results of an International Survey	14
Early Rejection and Graft Vasculopathy in DCD Hearts: A Comparison of Recovery Methods	14
Initial Analysis of Immune Phenotypes in Heart Transplant Recipients of the ALL IN HEART (Tocilizumab) Trial	14
Gut Reaction: Gastroesophageal Reflux Fuels De Novo DSA Development After Lung Transplant	14
A Rare Case of HeartMate 3 Pump Stoppage	14
Primary Graft Dysfunction Decreases Peak Lung Function After Transplantation: A Lung Transplant Outcomes Group (LTOG) Study	14
First Sub-Zero Cardiac Allograft Preservation and Reanimation Following 24-Hours of Isochoric Supercooled Preservation	14
Impact of Preoperative Opioid Use in Lung Transplant Recipients	14
Improving Efficiency in Pharmacist Led Thoracic Transplant Patient Medication Education	14
Tuberculosis Post Lung Transplantation - An Indian Experience	14
Long-Term Outcomes of Ventricular Assist Devices in Obese Pediatric Patients: An ACTION Registry Study	14
Porcine Mitochondria Transplantation in Human iPS-Cardiomyocytes and Intact Hearts	14
Patients with Acute Lung Rejection Have a Worse Outcome After Combined Heart-Lung Transplantation	14
Use of Newer Intravascular Microaxial Ambulatory Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock in Adult Congenital Heart Disease Patients	14
Donor Heart Preservation at 4-8°C Using Moderate Hypothermic Donor Heart Preservation Improves 4-year Survival in the US Guardian-Heart Registry	14
MHC Class II Matching Does Not Predict Survival in Organ and Bone Marrow Transplantation in Non-Human Primates	14
Reversion of Val(ganciclovir)-Resistance Associated Mutation in Two SOT Patients with Mismatch Serostatus for CMV (D+/R-)	14
Evaluating Postoperative Outcomes of Heart Transplant Recipients from Active COVID19 Positive and Negative Donors Using Induction Therapy	14
Application of Optical Mapping for Assessing Ischemic Regions in Donor Hearts: A Novel Approach to Monitoring Action Potential Hysteresis and Triangulation	14
Left Ventricular Stenting - A Novel Technique for LVAD Implantation in Patients with Restrictive Cardiomyopathy	14
Hemodynamics at Submaximal Exercise Independently Predict Outcomes in Severe Heart Failure	14
Use and Outcomes of Ex-Vivo Machine Perfusion (EVMP) in Donation After Brain Death (DBD) Heart Transplantation (HT)	13
The Impact of Functional Warm Ischemia Time on Procurement and Preservation Technique in DCD Heart Transplantation	13
Extended survival of 9- and 10-gene-edited pig heart xenografts with ischemia minimization and CD154 costimulation blockade-based immunosuppression	13
Dapagliflozin Use in Children with Heart Failure Undergoing Heart Transplantation	13
SAFETY OF BALLOON PULMONARY ANGIOPLASTY IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	13
Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported with CF-LVADs?	13
Outcomes of Explanted LVAD Patients with Heart Failure Relapse Requiring Heart Replacement Therapies: A VAD Wean Registry Analysis	13
Donor-Derived Cell-Free DNA as a Biomarker for the Effect of Daratumumab in Patients with Antibody-Mediated Rejection Post-Heart Transplant	13
Lung Ultrasound for Diagnosis of Primary Graft Dysfunction in Lung Transplantation Recipients	13
Barriers and opportunities in donation after circulatory death heart transplantation	13
ADAM10-Mediated VE-Cadherin Shedding May Increase the Risk of Sepsis for Heart Failure Patients Supported by Continuous-Flow Left Ventricular Assist Devices	13
Non-Ischemic Preservation of the Donor Heart in Heart Transplantation - A Randomized, Controlled, Multicenter Trial Using The Xvivo Heart Assist Preservation System for Hypothermic Oxygenated Perfusio	13
CD38 Antibody Daratumumab as an Add-On Rescue Therapy for AMR - First Report in Clinical Lung Transplantation	13
Donor sequence number is not associated with worse lung transplant outcomes regardless of transplant center case volume	13
Axillary Temporary Mechanical Circulatory Support to Bridge Cardiogenic Shock Patients to Heart Transplantation	12
Impact of Innate Rejection on Graft Survival in Heart Transplantation: Preliminary Findings on Missing-Self Induced Microvascular Rejection	12
Triheptanoin Use for Severe Neonatal Cardiomyopathy Secondary to Mitochondrial Trifunctional Protein Deficiency- A First Report	12
An Ocean of Difference? Donor and Recipient Risk Factor Perception from a Cross-National Survey	12
Lung Transplantation in Patients with Hermansky-Pudlak Syndrome	12
Clinician Assessed Versus Objective Measures of Frailty in Left Ventricular Assist Device Patients	12
Digoxin Reverses Angiogenic Dysregulation During HeartMate 3 Support by Inhibiting the HIF1-a Signaling Cascade and is Associated with Decreased Risk for Gastrointestinal Bleeding	12
Influence of Environmental Temperature on the Occurrence of Driveline Infection in LVAD Patients	12
Safety of Sodium Glucose Co-Transporter 2 Inhibitor Exposure Prior to Heart Transplantation	12
Coronavirus disease 2019 outcomes in heart transplant recipients: A large Australian cohort	12
Days Alive out of the Hospital After Placement of A Contemporary Left Ventricular Assist Device and Heart Transplantation	12
Between Metrics and Measures: KCCQ, CPET, and HF Prognosis	12
Identification and Clinical Course of Novel Pathogenic Variant of Transthyretin Amyloid Cardiomyopathy: P.arg54lys	12
Incorporating Donor Variables Improves Accuracy of One-Year Post-Transplant Survival Prediction for Adult Heart Transplant Recipients	12
Deglycosylation of Lung Reactive Autoantibodies Ameliorates Graft Injury Post Lung Transplant	12
Donation After Circulatory Death Heart Transplantation with Ex-Vivo Perfusion: Is It Ready for Prime Time?	12
Delayed Presentation of Hyperammonemia Syndrome After Lung Transplant	12
Characterization and Treatment of Iron Deficiency in Left Ventricular Assist Device Patients	12
Let Us Shock You! Multidisciplinary Team Approach to Cardiogenic Shock Improves Patient Outcomes and Reduces Complications	11
Estimating Prognosis Among Advanced Heart Failure Patients Referred for Advanced Heart Failure Therapies at the University Health Network	11
Outcomes in Patients with Acute Cellular Rejection Grade 1R: Is the Debate Over?	11
Essential Strategies to Sustain the First Cardiac Transplant Program in an Ultraperipheral Region: Extended Criteria Donor Hearts and Donation After Circulatory Death	11
Pump Supporting a Pump- Trials and Tribulations!	11
Leukotriene B4: A potential mediator and biomarker for cardiac allograft vasculopathy	11